Alogliptin Wins FDA Go-Ahead for Type 2 Diabetes

(MedPage Today) -- SILVER SPRING, Md. -- After a long delay, the FDA approved the oral drug alogliptin (Nesina) for treatment of adults with type 2 diabetes, as well as two products combining alogliptin with other antidiabetic drugs. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/01/alogliptin-wins-fda-go-ahead-for-type-2.html